Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)

NCT00734708 is registered in ClinicalTrials.gov with Kaken Pharmaceutical as lead sponsor.

NCT NCT00734708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00734708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)
Lead sponsor
Kaken Pharmaceutical
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
Not reported
Enrollment
328 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar bone loss, periodontal attachment loss, periodontitis